Liberate Bio
PrivateLast Round
Seed
Oct 15, 2025
Total Funding Raised
$31M
Company Overview
Liberate Bio is a biotechnology company developing a genetic medicine platform designed to enable targeted delivery of RNA therapies to immune cells beyond the liver.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Liberate Bio Comparables
Compare Liberate Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MOTE Therapeutics | 88% | |
| Mana.bio | 87% | |
| Hopewell Therapeutics | 87% | |
Liberate Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 15, 2025 |
Liberate Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Seed |
Liberate Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Liberate Bio's valuation, stock price, and market status.